Skip to main content
. 2019 Jul 26;10:843. doi: 10.3389/fphar.2019.00843

Figure 2.

Figure 2

CTAB enhanced DOX sensitivity on MCF-7/MDR cells. (A) Effect of DOX and DOX combined with CTAB on cell viability of MCF-7/MDR cells for 48 h. Mean values ± SD, *P < 0.05, MCF-7/MDR cells treated with different concentration of DOX for 48 h vs. MCF-7 cells treated with different concentration of DOX combined with CTAB for 48 h. (B) AMPK, p-AMPK, HIF-1α, and P-gp protein expression caused by CTAB treatment.